Skip to main content
logo
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.9100
-0.0900 (-9.00%)
At close: May 12, 2026, 4:00 PM EDT
0.9201
+0.0101 (1.11%)
After-hours: May 12, 2026, 5:26 PM EDT

Humacyte Revenue

In the year 2025, Humacyte had annual revenue of $2.04M. Humacyte had revenue of $467.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$2.04M
Revenue Growth
n/a
P/S Ratio
105.41
Revenue / Employee
$11,076
Employees
184
Market Cap
202.04M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.04M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20221.57M302.00K23.91%
Dec 31, 20211.26M-228.00K-15.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Keros Therapeutics244.06M
Heron Therapeutics154.90M
Fennec Pharmaceuticals44.64M
Orchestra BioMed Holdings33.48M
OmniAb28.94M
Sol-Gel Technologies19.39M
Alector18.42M
Adagene7.67M
Revenue Rankings

HUMA News

More News